• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对健康技术评估组织公众参与实践的国际调查。

An international survey of the public engagement practices of health technology assessment organizations.

机构信息

Centre for Applied Health Economics, School of Medicine, and Griffith Health Institute, Griffith University, Queensland, Australia.

出版信息

Value Health. 2013 Jan-Feb;16(1):155-63. doi: 10.1016/j.jval.2012.09.011.

DOI:10.1016/j.jval.2012.09.011
PMID:23337227
Abstract

OBJECTIVES

Many jurisdictions are moving toward greater public involvement in health technology assessment (HTA) processes. This study aims to provide a broad, cross-sectional indication of the extent and methods of public engagement in HTA, with a focus on which public are engaged, by what mechanisms, and the purpose of public engagement.

METHODS

An international Web-based survey of 217 organizations involved in HTA was undertaken. Contact e-mail addresses for targeted organizations were identified from the Internet.

RESULTS

Individuals from 39 (18%) of the contacted organizations completed a survey. The majority (67%) of responding HTA organizations undertake public engagement activities, predominantly involving lay representatives of organized groups (81%), and to a lesser extent individual patients/consumers (54%) or citizens/community members (54%). For organizations undertaking public engagement, mechanisms based on communication or consultation were the most common, although some organizations have used or intend to use participatory approaches, particularly the Citizens' Jury (8%) or Consensus Council (20%) methods. Respondents identified with a number of rationales and barriers for undertaking public engagement.

CONCLUSIONS

This survey provides further insight into the public engagement approaches that are used by HTA organizations in practice. In particular, it suggests a limited adoption of participatory methods to date, and interest in the use of social media. Study findings require further confirmation, due to limitations related to survey response. There is considerable opportunity for further research into pragmatic, robust, and meaningful approaches to public engagement to strengthen HTA policy and decision-making frameworks. An agenda for future research evolving from the survey responses is proposed.

摘要

目的

许多司法管辖区正在朝着让更多公众参与健康技术评估(HTA)过程的方向发展。本研究旨在广泛、跨部门地了解公众参与 HTA 的程度和方法,重点关注哪些公众参与、通过什么机制以及公众参与的目的。

方法

对 217 个参与 HTA 的组织进行了国际网络调查。从互联网上确定了目标组织的联系电子邮件地址。

结果

有 39 个(18%)联系组织的个人完成了一项调查。大多数(67%)参与 HTA 的组织开展了公众参与活动,主要涉及有组织团体的普通代表(81%),以及较少的个体患者/消费者(54%)或公民/社区成员(54%)。对于开展公众参与的组织而言,基于沟通或协商的机制最为常见,尽管一些组织已经使用或打算使用参与式方法,特别是公民陪审团(8%)或共识理事会(20%)方法。受访者提出了一些开展公众参与的理由和障碍。

结论

本调查进一步了解了 HTA 组织在实践中使用的公众参与方法。特别是,这表明迄今为止参与式方法的采用有限,并且对使用社交媒体感兴趣。由于与调查回复相关的限制,研究结果需要进一步确认。有很大的机会进一步研究实用、稳健和有意义的公众参与方法,以加强 HTA 政策和决策框架。从调查回复中提出了未来研究的议程。

相似文献

1
An international survey of the public engagement practices of health technology assessment organizations.一项针对健康技术评估组织公众参与实践的国际调查。
Value Health. 2013 Jan-Feb;16(1):155-63. doi: 10.1016/j.jval.2012.09.011.
2
Community views and perspectives on public engagement in health technology assessment decision making.社区对公众参与卫生技术评估决策的看法和观点。
Aust Health Rev. 2017 Mar;41(1):68-74. doi: 10.1071/AH15221.
3
Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study.公众参与卫生技术评估决策的偏好:一项混合方法研究的方案
BMC Med Inform Decis Mak. 2015 Jul 14;15:52. doi: 10.1186/s12911-015-0176-0.
4
PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.公众和患者参与卫生技术评估:行动框架
Int J Technol Assess Health Care. 2016 Jan;32(4):256-264. doi: 10.1017/S0266462316000362. Epub 2016 Sep 27.
5
Public engagement in health technology assessment and coverage decisions: a study of experiences in France, Germany, and the United Kingdom.公众参与卫生技术评估和覆盖决策:法国、德国和英国的经验研究。
J Health Polit Policy Law. 2013 Feb;38(1):89-122. doi: 10.1215/03616878-1898812. Epub 2012 Oct 10.
6
CONTRIBUTION OF STAKEHOLDER ENGAGEMENT TO THE IMPACT OF A HEALTH TECHNOLOGY ASSESSMENT: AN IRISH CASE STUDY.利益相关方参与对卫生技术评估影响的贡献:爱尔兰案例研究。
Int J Technol Assess Health Care. 2017 Jan;33(4):424-429. doi: 10.1017/S026646231700085X. Epub 2017 Oct 16.
7
What factors determine the choice of public engagement undertaken by health technology assessment decision-making organizations?哪些因素决定了卫生技术评估决策组织所采取的公众参与方式?
J Health Organ Manag. 2016 Sep 19;30(6):872-90. doi: 10.1108/JHOM-08-2015-0119.
8
Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes.明确公众在健康技术评估(HTA)和 HTA 决策过程中的角色。
Int J Technol Assess Health Care. 2020 Apr;36(2):87-95. doi: 10.1017/S0266462320000094. Epub 2020 Mar 10.
9
EVALUATION OF PATIENT AND PUBLIC INVOLVEMENT INITIATIVES IN HEALTH TECHNOLOGY ASSESSMENT: A SURVEY OF INTERNATIONAL AGENCIES.评估健康技术评估中的患者和公众参与倡议:对国际机构的调查。
Int J Technol Assess Health Care. 2017 Jan;33(6):715-723. doi: 10.1017/S0266462317000976. Epub 2017 Nov 10.
10
Moving cautiously: Public involvement and the health technology assessment community.谨慎前行:公众参与和卫生技术评估共同体。
Int J Technol Assess Health Care. 2011 Jan;27(1):43-9. doi: 10.1017/S0266462310001200. Epub 2011 Jan 25.

引用本文的文献

1
Deliberative processes in health technology assessment of medicines: the case of Spain.药品卫生技术评估中的审议过程:以西班牙为例。
Int J Technol Assess Health Care. 2023 Jul 5;39(1):e50. doi: 10.1017/S0266462323000387.
2
Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries.中东欧国家中患者参与健康技术评估的潜在障碍。
Front Public Health. 2022 Jul 28;10:922708. doi: 10.3389/fpubh.2022.922708. eCollection 2022.
3
Public engagement in health technology assessment in Brazil: the case of the public consultation on National Clinical Guidelines for Care in Normal Birth.
巴西卫生技术评估中的公众参与:国家正常分娩护理临床指南公开咨询的案例。
BMC Public Health. 2021 Oct 9;21(1):1825. doi: 10.1186/s12889-021-11855-w.
4
Limited role of patient input in specialty drug coverage policies.患者意见在专科药物保险政策中作用有限。
J Manag Care Spec Pharm. 2021 Aug;27(8):1067-1076. doi: 10.18553/jmcp.2021.27.8.1067.
5
Public values and plurality in health priority setting: What to do when people disagree and why we should care about reasons as well as choices.卫生优先事项设定中的公共价值观与多元性:当人们意见分歧时该怎么做,以及为何我们不仅应关注选择,还应关注理由。
Soc Sci Med. 2021 May;277:113892. doi: 10.1016/j.socscimed.2021.113892. Epub 2021 Apr 2.
6
Patient and public involvement in health technology decision-making processes in Brazil.巴西卫生技术决策过程中的患者和公众参与。
Rev Saude Publica. 2020 Dec 11;54:136. doi: 10.11606/s1518-8787.2020054002453. eCollection 2020.
7
Social participation in the health technology incorporation process into Unified Health System.社会参与卫生技术纳入统一卫生系统的过程。
Rev Saude Publica. 2019 Dec 20;53:109. doi: 10.11606/S1518-8787.2019053001420. eCollection 2019.
8
Financial interests of patient organisations contributing to technology assessment at England's National Institute for Health and Care Excellence: policy review.患者组织对英格兰国家卫生与保健优化研究所技术评估的财务利益贡献:政策回顾。
BMJ. 2019 Jan 16;364:k5300. doi: 10.1136/bmj.k5300.
9
Patient advocate perspectives on involvement in HTA: an international snapshot.患者权益倡导者对参与卫生技术评估的看法:国际概览
Res Involv Engagem. 2017 Jan 10;3:2. doi: 10.1186/s40900-016-0052-9. eCollection 2017.
10
It's not evidence, it's insight: bringing patients' perspectives into health technology appraisal at NICE.这并非证据,而是深刻见解:将患者的观点纳入英国国家卫生与临床优化研究所的卫生技术评估之中。
Res Involv Engagem. 2016 Mar 24;2:4. doi: 10.1186/s40900-016-0018-y. eCollection 2016.